These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34213323)

  • 1. pdCSM-cancer: Using Graph-Based Signatures to Identify Small Molecules with Anticancer Properties.
    Al-Jarf R; de Sá AGC; Pires DEV; Ascher DB
    J Chem Inf Model; 2021 Jul; 61(7):3314-3322. PubMed ID: 34213323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pdCSM-PPI: Using Graph-Based Signatures to Identify Protein-Protein Interaction Inhibitors.
    Rodrigues CHM; Pires DEV; Ascher DB
    J Chem Inf Model; 2021 Nov; 61(11):5438-5445. PubMed ID: 34719929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures.
    Velloso JPL; Ascher DB; Pires DEV
    Bioinform Adv; 2021; 1(1):vbab031. PubMed ID: 34901870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. embryoTox: Using Graph-Based Signatures to Predict the Teratogenicity of Small Molecules.
    Aljarf R; Tang S; Pires DEV; Ascher DB
    J Chem Inf Model; 2023 Jan; 63(2):432-441. PubMed ID: 36595441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mycoCSM: Using Graph-Based Signatures to Identify Safe Potent Hits against Mycobacteria.
    Pires DEV; Ascher DB
    J Chem Inf Model; 2020 Jul; 60(7):3450-3456. PubMed ID: 32615035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. toxCSM: comprehensive prediction of small molecule toxicity profiles.
    de Sá AGC; Long Y; Portelli S; Pires DEV; Ascher DB
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35998885
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Iftkhar S; de Sá AGC; Velloso JPL; Aljarf R; Pires DEV; Ascher DB
    J Chem Inf Model; 2022 Oct; 62(20):4827-4836. PubMed ID: 36219164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. kinCSM: Using graph-based signatures to predict small molecule CDK2 inhibitors.
    Zhou Y; Al-Jarf R; Alavi A; Nguyen TB; Rodrigues CHM; Pires DEV; Ascher DB
    Protein Sci; 2022 Nov; 31(11):e4453. PubMed ID: 36305769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cropCSM: designing safe and potent herbicides with graph-based signatures.
    Pires DEV; Stubbs KA; Mylne JS; Ascher DB
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35211724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. epitope1D: accurate taxonomy-aware B-cell linear epitope prediction.
    da Silva BM; Ascher DB; Pires DEV
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37039696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mmCSM-PPI: predicting the effects of multiple point mutations on protein-protein interactions.
    Rodrigues CHM; Pires DEV; Ascher DB
    Nucleic Acids Res; 2021 Jul; 49(W1):W417-W424. PubMed ID: 33893812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided machine learning prediction of drug resistance mutations in Abelson 1 kinase.
    Zhou Y; Portelli S; Pat M; Rodrigues CHM; Nguyen TB; Pires DEV; Ascher DB
    Comput Struct Biotechnol J; 2021; 19():5381-5391. PubMed ID: 34667533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.
    Kathad U; Kulkarni A; McDermott JR; Wegner J; Carr P; Biyani N; Modali R; Richard JP; Sharma P; Bhatia K
    BMC Bioinformatics; 2021 Mar; 22(1):102. PubMed ID: 33653269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinact: a computational approach for predicting activating missense mutations in protein kinases.
    Rodrigues CH; Ascher DB; Pires DE
    Nucleic Acids Res; 2018 Jul; 46(W1):W127-W132. PubMed ID: 29788456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSM-carbohydrate: protein-carbohydrate binding affinity prediction and docking scoring function.
    Nguyen TB; Pires DEV; Ascher DB
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34882232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSMDA: Target and symptom-based computational model for miRNA-disease-association prediction.
    Uthayopas K; de Sá AGC; Alavi A; Pires DEV; Ascher DB
    Mol Ther Nucleic Acids; 2021 Dec; 26():536-546. PubMed ID: 34631283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSM-AB: graph-based antibody-antigen binding affinity prediction and docking scoring function.
    Myung Y; Pires DEV; Ascher DB
    Bioinformatics; 2022 Jan; 38(4):1141-1143. PubMed ID: 34734992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters.
    Stork C; Chen Y; Šícho M; Kirchmair J
    J Chem Inf Model; 2019 Mar; 59(3):1030-1043. PubMed ID: 30624935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mmCSM-NA: accurately predicting effects of single and multiple mutations on protein-nucleic acid binding affinity.
    Nguyen TB; Myung Y; de Sá AGC; Pires DEV; Ascher DB
    NAR Genom Bioinform; 2021 Dec; 3(4):lqab109. PubMed ID: 34805992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines.
    Singh H; Kumar R; Singh S; Chaudhary K; Gautam A; Raghava GP
    BMC Cancer; 2016 Feb; 16():77. PubMed ID: 26860193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.